Anuraag S Parikh1, Sidharth V Puram2, William C Faquin1, Jeremy D Richmon1, Kevin S Emerick1, Daniel G Deschler1, Mark A Varvares1, Itay Tirosh3, Bradley E Bernstein4, Derrick T Lin5. 1. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA, USA; Department of Otolaryngology, Harvard Medical School, Boston, MA, USA. 2. Department of Otolaryngology-Head and Neck Surgery and Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: sidpuram@wustl.edu. 3. Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. 4. Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA. 5. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA, USA; Department of Otolaryngology, Harvard Medical School, Boston, MA, USA. Electronic address: Derrick_Lin@MEEI.harvard.edu.
Abstract
OBJECTIVES: Quantify by immunohistochemistry (IHC) a partial epithelial-to-mesenchymal transition (p-EMT) population in oral cavity squamous cell carcinoma (OCSCC) and determine its predictive value for lymph node metastasis. METHODS: Tissue microarrays (TMA) were created using 2 mm cores from 99 OCSCC patients (47 with low volume T2 disease, 52 with high volume T4 disease, and ∼50% in each group with nodal metastasis). IHC staining was performed for three validated p-EMT markers (PDPN, LAMB3, LAMC2) and one marker of well-differentiated epithelial cells (SPRR1B). Staining was quantified in a blinded manner by two reviewers. Tumors were classified as malignant basal subtype based on staining for the four markers. In this subset, the p-EMT score was computed as the average of p-EMT markers. RESULTS: 84 tumors were classified as malignant basal. There was 87% inter-rater consistency in marker quantification. There were associations of p-EMT scores with higher grade (2.15 vs. 1.92, p = 0.04), PNI (2.13 vs. 1.83, p = 0.003), and node positivity (2.09 vs. 1.87, p = 0.02), including occult node positivity (56% vs. 19%, p = 0.005). P-EMT was independently associated with nodal metastasis in a multivariate analysis (OR 3.12, p = 0.039). Overall and disease free survival showed trends towards being diminished in the p-EMT high group. CONCLUSIONS: IHC quantification of p-EMT in OCSCC primary tumors is reliably associated with nodal metastasis, PNI, and high grade. With prospective validation, p-EMT biomarkers may aid in decision-making over whether to perform a neck dissection in the N0 neck and/or for adjuvant therapy planning.
OBJECTIVES: Quantify by immunohistochemistry (IHC) a partial epithelial-to-mesenchymal transition (p-EMT) population in oral cavity squamous cell carcinoma (OCSCC) and determine its predictive value for lymph node metastasis. METHODS: Tissue microarrays (TMA) were created using 2 mm cores from 99 OCSCCpatients (47 with low volume T2 disease, 52 with high volume T4 disease, and ∼50% in each group with nodal metastasis). IHC staining was performed for three validated p-EMT markers (PDPN, LAMB3, LAMC2) and one marker of well-differentiated epithelial cells (SPRR1B). Staining was quantified in a blinded manner by two reviewers. Tumors were classified as malignant basal subtype based on staining for the four markers. In this subset, the p-EMT score was computed as the average of p-EMT markers. RESULTS: 84 tumors were classified as malignant basal. There was 87% inter-rater consistency in marker quantification. There were associations of p-EMT scores with higher grade (2.15 vs. 1.92, p = 0.04), PNI (2.13 vs. 1.83, p = 0.003), and node positivity (2.09 vs. 1.87, p = 0.02), including occult node positivity (56% vs. 19%, p = 0.005). P-EMT was independently associated with nodal metastasis in a multivariate analysis (OR 3.12, p = 0.039). Overall and disease free survival showed trends towards being diminished in the p-EMT high group. CONCLUSIONS: IHC quantification of p-EMT in OCSCC primary tumors is reliably associated with nodal metastasis, PNI, and high grade. With prospective validation, p-EMT biomarkers may aid in decision-making over whether to perform a neck dissection in the N0 neck and/or for adjuvant therapy planning.
Authors: Zinaida A Dubeykovskaya; Nguyen Huu Tu; Paulina D Ramírez Garcia; Brian L Schmidt; Donna G Albertson Journal: Adv Biol (Weinh) Date: 2022-07-08
Authors: Riley D Z Mullins; Ananya Pal; Thomas F Barrett; Molly E Heft Neal; Sidharth V Puram Journal: Cancer Res Date: 2022-07-05 Impact factor: 13.312
Authors: Gabriela S Kinker; Alissa C Greenwald; Rotem Tal; Zhanna Orlova; Michael S Cuoco; James M McFarland; Allison Warren; Christopher Rodman; Jennifer A Roth; Samantha A Bender; Bhavna Kumar; James W Rocco; Pedro A C M Fernandes; Christopher C Mader; Hadas Keren-Shaul; Alexander Plotnikov; Haim Barr; Aviad Tsherniak; Orit Rozenblatt-Rosen; Valery Krizhanovsky; Sidharth V Puram; Aviv Regev; Itay Tirosh Journal: Nat Genet Date: 2020-10-30 Impact factor: 41.307
Authors: Aditi Bhattacharya; Malvin N Janal; Ratna Veeramachaneni; Igor Dolgalev; Zinaida Dubeykovskaya; Nguyen Huu Tu; Hyesung Kim; Susanna Zhang; Angie K Wu; Mari Hagiwara; A Ross Kerr; Mark D DeLacure; Brian L Schmidt; Donna G Albertson Journal: Sci Rep Date: 2020-09-07 Impact factor: 4.379